Ampicillin Dosage for Enterococcus faecalis Infection
For a patient with normal renal function and confirmed Enterococcus faecalis infection, administer ampicillin 2 g IV every 4 hours (12 g/24 hours total) in combination with either gentamicin or ceftriaxone, depending on aminoglycoside susceptibility and clinical context. 1
Treatment Algorithm Based on Infection Type and Susceptibility
For Endocarditis (Most Common Serious E. faecalis Infection)
Aminoglycoside-Susceptible Strains:
- Ampicillin 2 g IV every 4 hours (12 g/24 hours in 6 divided doses) 1
- Plus gentamicin 3 mg/kg/day IV or IM in 1 dose for 2-6 weeks 1
- Duration: 4 weeks for native valve with symptoms <3 months; 6 weeks for symptoms >3 months or prosthetic valve 1
High-Level Aminoglycoside Resistance (HLAR):
- Ampicillin 2 g IV every 4 hours (12 g/24 hours) 1
- Plus ceftriaxone 2 g IV every 12 hours (4 g/24 hours) 1
- Duration: 6 weeks regardless of symptom duration 1
- This combination is the preferred regimen for HLAR E. faecalis and achieves 100% cure rates in patients completing therapy 2
For Non-Endocarditis Infections
Soft Tissue/Wound Infections:
- Ampicillin 2 g IV every 6 hours for 7-14 days depending on clinical response 3
- Transition to oral amoxicillin 500 mg three times daily once clinical improvement documented and oral intake tolerated 3
Orthopedic/Bone Infections:
- Ampicillin 8-16 g/day IV (2 g every 4-6 hours) 4
- Plus ceftriaxone 2-4 g/day 4
- Duration: Median 25 days IV followed by oral amoxicillin continuation 4
Bacteremia (Non-Endocarditis):
- Ampicillin 2 g IV every 4 hours 1
- Duration: 4 weeks for uncomplicated bacteremia; 6 weeks for complicated cases 5
Key Dosing Principles
Standard Ampicillin Dosing:
- The consistent recommendation across all major guidelines is 2 g every 4 hours (12 g/24 hours total) for serious E. faecalis infections 1
- This dosing achieves adequate serum concentrations to maintain levels above the MIC for time-dependent killing 6
- For patients with normal renal function, no dose adjustment is needed 1
Combination Therapy Rationale:
- Ampicillin alone is bacteriostatic against enterococci; combination therapy achieves bactericidal activity 1, 2
- Gentamicin provides synergy but carries nephrotoxicity risk, particularly in elderly patients 1
- Ceftriaxone combination is equally effective and safer for patients at risk for aminoglycoside toxicity 2, 4
Alternative Regimens for Special Circumstances
Penicillin Allergy:
- Vancomycin 30 mg/kg/day IV in 2 divided doses (target trough ≥20 mg/L for serious infections) 1
- Plus gentamicin 3 mg/kg/day for 6 weeks 1
- Vancomycin should only be used when β-lactams cannot be tolerated, as ampicillin combinations are more active 1
Beta-Lactamase Producing Strains:
- Ampicillin-sulbactam 12 g/24 hours IV in 4 divided doses 1
- Plus gentamicin if susceptible 1
- Duration: 6 weeks 1
Acute Kidney Injury:
- Linezolid 600 mg IV or PO every 12 hours (no renal adjustment needed) 5
- Avoid aminoglycoside-containing regimens due to nephrotoxicity risk 5
- Monitor complete blood counts weekly for hematologic toxicity 5
Critical Monitoring Parameters
Renal Function:
- Monitor creatinine clearance weekly (twice weekly if using aminoglycosides) 1
- Avoid streptomycin if creatinine clearance <50 mL/min 1
- Patients developing renal impairment on aminoglycosides should switch to double β-lactam regimen 1
Aminoglycoside Levels (if used):
- Gentamicin: Target peak 3-4 μg/mL, trough <1 μg/mL 1
- Streptomycin: Target peak 20-35 μg/mL, trough <10 μg/mL 1
Clinical Response:
- Assess for fever resolution, decreased leukocytosis within 48-72 hours 3
- Obtain repeat blood cultures to document clearance 3
- Monitor for treatment failure requiring surgical intervention 4
Common Pitfalls and How to Avoid Them
Inadequate Duration:
- Do not shorten therapy below recommended durations; endocarditis requires minimum 4-6 weeks 1
- Prosthetic valve infections always require 6 weeks minimum 1
Inappropriate Monotherapy:
- Never use ampicillin alone for serious E. faecalis infections; bactericidal combination is essential 1, 2
- Single-agent therapy leads to treatment failures and relapses 2
Ignoring Aminoglycoside Resistance:
- Always test for high-level gentamicin and streptomycin resistance 1
- If HLAR detected, switch to ampicillin-ceftriaxone combination rather than continuing ineffective aminoglycoside 1, 2
Source Control Failure:
- Antibiotic therapy alone is insufficient without adequate source control (debridement, abscess drainage, device removal when indicated) 3, 4
- Retained foreign material may require prolonged suppressive therapy or removal for cure 4
Ceftriaxone Dosing Errors: